{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:38:41Z","timestamp":1792604321847,"version":"4.5.0"},"publisher-location":"Cham","reference-count":115,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032294364","type":"print"},{"value":"9783032294371","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-29437-1_17","type":"book-chapter","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:53:03Z","timestamp":1792601583000},"page":"269-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mass Spectrometry-Based Proteomics Analysis of Breast Milk for Breast Cancer Biomarker Discovery: An Update"],"prefix":"10.1007","author":[{"given":"Aneeta","family":"Arshad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshanak","family":"Aslebagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brindusa Alina","family":"Petre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batuhan","family":"Uzunoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rylie","family":"Flack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen F.","family":"Arcaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costel C.","family":"Darie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2027,1,23]]},"reference":[{"issue":"4","key":"17_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","volume":"26","author":"LA Torre","year":"2017","unstructured":"Torre LA et al. (2017) Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev 26(4):444\u2013457","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"17_CR2","volume-title":"SEER cancer statistics factsheets: breast cancer","author":"NC Institute","year":"2018","unstructured":"Institute, NC, 2018. SEER cancer statistics factsheets: breast cancer. National Cancer Institute"},{"issue":"1","key":"17_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7326\/M18-1323","volume":"170","author":"HB Nichols","year":"2018","unstructured":"Nichols HB et al. (2018) Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies. Ann Intern Med 170(1):22\u201330. https:\/\/doi.org\/10.7326\/M18-1323","journal-title":"Ann Intern Med"},{"issue":"2","key":"17_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/BF02305802","volume":"3","author":"BO Anderson","year":"1996","unstructured":"Anderson BO et al. (1996) Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol 3(2):204\u2013211","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"17_CR5","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/cncr.26643","volume":"118","author":"VF Borges","year":"2012","unstructured":"Borges VF, Schedin PJ (2012) Pregnancy-associated breast cancer: an entity needing refinement of the definition. Cancer 118(13):3226\u20133228","journal-title":"Cancer"},{"issue":"13","key":"17_CR6","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1002\/cncr.26654","volume":"118","author":"CG Murphy","year":"2012","unstructured":"Murphy CG et al. (2012) Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer. Cancer 118(13):3254\u20133259","journal-title":"Cancer"},{"issue":"4","key":"17_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.diii.2013.12.021","volume":"95","author":"A Langer","year":"2014","unstructured":"Langer A et al. (2014) A single-institution study of 117 pregnancy-associated breast cancers (PABC): presentation, imaging, clinicopathological data and outcome. Diagn Interv Imaging 95(4):435\u2013441","journal-title":"Diagn Interv Imaging"},{"key":"17_CR8","volume-title":"Breast cancer facts and figures 2013\u20132014","author":"AC Society","year":"2013","unstructured":"Society, AC, 2013. Breast cancer facts and figures 2013\u20132014. American Cancer Society"},{"key":"17_CR9","volume-title":"Screening for breast cancer, topic page","author":"USPST Force","year":"2010","unstructured":"Force, USPST, 2010. Screening for breast cancer, topic page. U.S. Preventive Services Task Force"},{"issue":"3","key":"17_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000381823","volume":"10","author":"I Beyer","year":"2015","unstructured":"Beyer I et al. (2015) Breast lesions during pregnancy\u2014a diagnostic challenge: case report. Breast Care (Basel) 10(3):207\u2013210","journal-title":"Breast Care (Basel)"},{"issue":"5","key":"17_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s13244-012-0211-y","volume":"4","author":"S Joshi","year":"2013","unstructured":"Joshi S et al. (2013) Breast disease in the pregnant and lactating patient: radiological-pathological correlation. Insights Imaging 4(5):527\u2013538","journal-title":"Insights Imaging"},{"issue":"3","key":"17_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10552-014-0498-8","volume":"26","author":"HP Yang","year":"2015","unstructured":"Yang HP et al. (2015) Association of TGF-\u03b22 levels in breast milk with severity of breast biopsy diagnosis. Cancer Causes Control 26(3):345\u2013354","journal-title":"Cancer Causes Control"},{"issue":"4","key":"17_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1177\/0890334412453205","volume":"28","author":"KF Arcaro","year":"2012","unstructured":"Arcaro KF et al. (2012) Differential expression of cancer-related proteins in paired breast milk samples from women with breast cancer. J Hum Lact 28(4):543\u2013546","journal-title":"J Hum Lact"},{"issue":"7","key":"17_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4161\/epi.5.7.12961","volume":"5","author":"CM Wong","year":"2010","unstructured":"Wong CM et al. (2010) Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics 5(7):645\u2013655","journal-title":"Epigenetics"},{"issue":"1","key":"17_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-100","volume":"12","author":"W Qin","year":"2012","unstructured":"Qin W et al. (2012) Differential expression of cancer associated proteins in breast milk based on age at first full term pregnancy. BMC Cancer 12(1):100","journal-title":"BMC Cancer"},{"issue":"12","key":"17_CR16","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.4161\/epi.6.12.18280","volume":"6","author":"EP Browne","year":"2011","unstructured":"Browne EP et al. (2011) Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy. Epigenetics 6(12):1425\u20131435","journal-title":"Epigenetics"},{"issue":"1","key":"17_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10549-016-3796-x","volume":"157","author":"J Murphy","year":"2016","unstructured":"Murphy J et al. (2016) Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations. Breast Cancer Res Treat 157(1):13\u201322","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"17_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/jnci\/djs505","volume":"105","author":"JM Faupel-Badger","year":"2012","unstructured":"Faupel-Badger JM et al. (2012) Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute\u2013sponsored workshop. J Natl Cancer Inst 105(3):166\u2013174. https:\/\/doi.org\/10.1093\/jnci\/djs505","journal-title":"J Natl Cancer Inst"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/978-3-319-06068-2_19","volume":"806","author":"SS Schneider","year":"2014","unstructured":"Schneider SS et al. (2014) Using breast milk to assess breast cancer risk: the role of mass spectrometry-based proteomics. Adv Exp Med Biol 806:399\u2013408","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"17_CR20","first-page":"37","volume":"7","author":"P Thompson","year":"1998","unstructured":"Thompson P et al. (1998) Exfoliated ductal epithelial cells in human breast milk: a source of target tissue DNA for molecular epidemiologic studies of breast cancer. Cancer Epidemiol Biomarkers Prev 7(1):37\u201342","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"17_CR21","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3892\/ijmm.2014.1677","volume":"33","author":"Y-Q Gu","year":"2014","unstructured":"Gu Y-Q et al. (2014) miRNA profiling reveals a potential role of milk stasis in breast carcinogenesis. Int J Mol Med 33(5):1243\u20131249","journal-title":"Int J Mol Med"},{"issue":"4","key":"17_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/elps.201700123","volume":"39","author":"R Aslebagh","year":"2018","unstructured":"Aslebagh R et al. (2018) Proteomics analysis of human breast milk to assess breast cancer risk. Electrophoresis 39(4):653\u2013665","journal-title":"Electrophoresis"},{"issue":"14","key":"17_CR23","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/elps.201800025","volume":"39","author":"R Aslebagh","year":"2018","unstructured":"Aslebagh R et al. (2018) Comparative two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) of human milk to identify dysregulated proteins in breast cancer. Electrophoresis 39(14):1723\u20131734","journal-title":"Electrophoresis"},{"key":"17_CR24","volume-title":"Fertility of Women in the United States: 2012","author":"L Monte","year":"2014","unstructured":"Monte, L, Ellis, R, 2014. Fertility of Women in the United States: 2012. U.S. Census Bureau"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/978-3-030-15950-4_26","volume":"1140","author":"R Aslebagh","year":"2019","unstructured":"Aslebagh R et al. (2019) Combinatorial electrophoresis and mass spectrometry-based proteomics in breast milk for breast cancer biomarker discovery. Adv Exp Med Biol 1140:451\u2013467","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"17_CR26","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1158\/1078-0432.CCR-04-2280","volume":"11","author":"N Linder","year":"2005","unstructured":"Linder N et al. (2005) Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer. Clin Cancer Res 11(12):4372\u20134381","journal-title":"Clin Cancer Res"},{"issue":"9","key":"17_CR27","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1158\/1541-7786.MCR-11-0176","volume":"9","author":"MA Fini","year":"2011","unstructured":"Fini MA et al. (2011) Contribution of xanthine oxidoreductase to mammary epithelial and breast cancer cell differentiation in part modulates inhibitor of differentiation-1. Mol Cancer Res molcanres 9(9):1242\u201354. https:\/\/doi.org\/10.1158\/1541-7786.MCR-11-0176 Epub 2011 Jul 20","journal-title":"Mol Cancer Res molcanres"},{"issue":"1","key":"17_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-3-39","volume":"3","author":"G Schramm","year":"2010","unstructured":"Schramm G et al. (2010) Analyzing the regulation of metabolic pathways in human breast cancer. BMC Med Genomics 3(1):39","journal-title":"BMC Med Genomics"},{"issue":"10","key":"17_CR29","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/0277-5379(87)90100-3","volume":"23","author":"J B\u00e1rtkov\u00e1","year":"1987","unstructured":"B\u00e1rtkov\u00e1 J et al. (1987) Lack of \u03b2-casein production by human breast tumours revealed by monoclonal antibodies. Eur J Cancer Clin Oncol 23(10):1557\u20131563","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"4","key":"17_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2217\/fon.10.11","volume":"6","author":"R Flavin","year":"2010","unstructured":"Flavin R et al. (2010) Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol 6(4):551\u2013562","journal-title":"Future Oncol"},{"key":"17_CR31","unstructured":"Wang YY et al (2004) Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer. J Exp Ther Oncol 4(2):101\u2013110"},{"issue":"1","key":"17_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0304-3835(01)00464-5","volume":"167","author":"YY Wang","year":"2001","unstructured":"Wang YY et al. (2001) Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett 167(1):99\u2013104","journal-title":"Cancer Lett"},{"issue":"11","key":"17_CR33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1349-7006.2004.tb02198.x","volume":"95","author":"J Yamamura","year":"2004","unstructured":"Yamamura J et al. (2004) mRNA expression level of estrogen-inducible gene, \u03b11-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers. Cancer Sci 95(11):887\u2013892","journal-title":"Cancer Sci"},{"issue":"8","key":"17_CR34","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/1097-0142(19951015)76:8<1368::AID-CNCR2820760812>3.0.CO;2-N","volume":"76","author":"M Higashiyama","year":"1995","unstructured":"Higashiyama M et al. (1995) Alpha-1-antichymotrypsin expression in lung adenocarcinoma and its possible association with tumor progression. Cancer 76(8):1368\u20131376","journal-title":"Cancer"},{"issue":"3","key":"17_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3346\/jkms.1997.12.3.228","volume":"12","author":"NH Cho","year":"1997","unstructured":"Cho NH, Park C, Park DS (1997) Expression of alpha-1-antichymotrypsin in prostate carcinoma. J Korean Med Sci 12(3):228\u2013233","journal-title":"J Korean Med Sci"},{"issue":"9","key":"17_CR36","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1111\/jcmm.13145","volume":"21","author":"D Channaveerappa","year":"2017","unstructured":"Channaveerappa D et al. (2017) Atrial electrophysiological and molecular remodelling induced by obstructive sleep apnoea. J Cell Mol Med 21(9):2223\u20132235","journal-title":"J Cell Mol Med"},{"issue":"1","key":"17_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-7-8","volume":"7","author":"LA Cole","year":"2009","unstructured":"Cole LA (2009) New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol 7(1):8","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"17_CR38","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2165\/00003495-199957040-00001","volume":"57","author":"JJ Gregory","year":"1999","unstructured":"Gregory JJ, Finlay JL (1999) \u03b1-Fetoprotein and \u03b2-human chorionic gonadotropin. Drugs 57(4):463\u2013467","journal-title":"Drugs"},{"issue":"8","key":"17_CR39","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/bjc.1996.513","volume":"74","author":"RE Hall","year":"1996","unstructured":"Hall RE et al. (1996) Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer. Br J Cancer 74(8):1175","journal-title":"Br J Cancer"},{"issue":"2","key":"17_CR40","first-page":"310","volume":"144","author":"I Diez-Itza","year":"1994","unstructured":"Diez-Itza I et al. (1994) Expression and prognostic significance of apolipoprotein D in breast cancer. Am J Pathol 144(2):310","journal-title":"Am J Pathol"},{"issue":"3","key":"17_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1189\/jlb.0107053","volume":"82","author":"J Sturge","year":"2007","unstructured":"Sturge J et al. (2007) Mannose receptor regulation of macrophage cell migration. J Leukoc Biol 82(3):585\u2013593","journal-title":"J Leukoc Biol"},{"issue":"2","key":"17_CR42","doi-asserted-by":"publisher","first-page":"e57697","DOI":"10.1371\/journal.pone.0057697","volume":"8","author":"NJ Brown","year":"2013","unstructured":"Brown NJ et al. (2013) Lactate dehydrogenase-B is silenced by promoter methylation in a high frequency of human breast cancers. PLoS One 8(2):e57697","journal-title":"PLoS One"},{"issue":"4","key":"17_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/iub.1485","volume":"68","author":"L Zhao","year":"2016","unstructured":"Zhao L et al. (2016) Association study between genome-wide significant variants of vitamin B12 metabolism and gastric cancer in a han Chinese population. IUBMB Life 68(4):303\u2013310","journal-title":"IUBMB Life"},{"issue":"1","key":"17_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13277-013-1017-3","volume":"35","author":"DC Castillo-Tong","year":"2014","unstructured":"Castillo-Tong DC et al. (2014) Association of myeloperoxidase with ovarian cancer. Tumor Biol 35(1):141\u2013148","journal-title":"Tumor Biol"},{"issue":"4","key":"17_CR45","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.3390\/cancers3044269","volume":"3","author":"VA Spencer","year":"2011","unstructured":"Spencer VA (2011) Actin\u2014towards a deeper understanding of the relationship between tissue context, cellular function and tumorigenesis. Cancers 3(4):4269\u20134280","journal-title":"Cancers"},{"issue":"4","key":"17_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF00049520","volume":"9","author":"WG Stetler-Stevenson","year":"1990","unstructured":"Stetler-Stevenson WG (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9(4):289\u2013303","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"17_CR47","first-page":"1349","volume":"46","author":"RT Kao","year":"1986","unstructured":"Kao RT, Stern R (1986) Collagenases in human breast carcinoma cell lines. Cancer Res 46(3):1349\u20131354","journal-title":"Cancer Res"},{"issue":"1","key":"17_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0304-3835(94)90136-8","volume":"76","author":"X-H Liu","year":"1994","unstructured":"Liu X-H, Rose DP (1994) Stimulation of type IV collagenase expression by linoleic acid in a metastatic human breast cancer cell line. Cancer Lett 76(1):71\u201377","journal-title":"Cancer Lett"},{"issue":"3","key":"17_CR49","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1023\/A:1006639214618","volume":"17","author":"U Benbow","year":"1999","unstructured":"Benbow U et al. (1999) Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid. Clin Exp Metastasis 17(3):231\u2013238","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"17_CR50","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1749-6632.2001.tb03525.x","volume":"936","author":"P Simpson-Haidaris","year":"2001","unstructured":"Simpson-Haidaris P, Rybarczyk B (2001) Tumors and fibrinogen. Ann NY Acad Sci 936(1):406\u2013425","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"17_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4149\/neo_2010_03_253","volume":"57","author":"L Wang","year":"2010","unstructured":"Wang L et al. (2010) Annexin A1 expression and its prognostic significance in human breast cancer. Neoplasma 57(3):253\u2013259","journal-title":"Neoplasma"},{"issue":"1","key":"17_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6890-11-13","volume":"11","author":"L Kloth","year":"2011","unstructured":"Kloth L et al. (2011) Decrease in thyroid adenoma associated (THADA) expression is a marker of dedifferentiation of thyroid tissue. BMC Clin Pathol 11(1):13","journal-title":"BMC Clin Pathol"},{"issue":"4","key":"17_CR53","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/modpathol.2010.1","volume":"23","author":"DA Ostler","year":"2010","unstructured":"Ostler DA et al. (2010) Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases. Mod Pathol 23(4):567","journal-title":"Mod Pathol"},{"issue":"3","key":"17_CR54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/modpathol.2009.191","volume":"23","author":"BK Straub","year":"2010","unstructured":"Straub BK et al. (2010) Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis. Mod Pathol 23(3):480","journal-title":"Mod Pathol"},{"issue":"1","key":"17_CR55","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2012.11.047","volume":"516","author":"S Divyya","year":"2013","unstructured":"Divyya S et al. (2013) Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk. Gene 516(1):76\u201381","journal-title":"Gene"},{"issue":"3","key":"17_CR56","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/jcb.21491","volume":"102","author":"X Wang","year":"2007","unstructured":"Wang X et al. (2007) Targeted treatment of prostate cancer. J Cell Biochem 102(3):571\u2013579","journal-title":"J Cell Biochem"},{"issue":"8","key":"17_CR57","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00432-015-1937-y","volume":"141","author":"S Xiao","year":"2015","unstructured":"Xiao S et al. (2015) The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin. J Cancer Res Clin Oncol 141(8):1465\u20131474","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"17_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-15-1","volume":"15","author":"F Sun","year":"2015","unstructured":"Sun F et al. (2015) Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival. BMC Cancer 15(1):1","journal-title":"BMC Cancer"},{"issue":"1","key":"17_CR59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/JTO.0b013e3182307f62","volume":"7","author":"Y-J Kwon","year":"2012","unstructured":"Kwon Y-J et al. (2012) Genome-wide analysis of DNA methylation and the gene expression change in lung cancer. J Thorac Oncol 7(1):20\u201333","journal-title":"J Thorac Oncol"},{"issue":"7","key":"17_CR60","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1210\/er.2008-0032","volume":"29","author":"GM Gibbs","year":"2008","unstructured":"Gibbs GM, Roelants K, O\u2019bryan MK (2008) The CAP superfamily: cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins\u2014roles in reproduction, cancer, and immune defense. Endocr Rev 29(7):865\u2013897","journal-title":"Endocr Rev"},{"issue":"2","key":"17_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.canlet.2006.02.017","volume":"244","author":"G Orend","year":"2006","unstructured":"Orend G, Chiquet-Ehrismann R (2006) Tenascin-C induced signaling in cancer. Cancer Lett 244(2):143\u2013163","journal-title":"Cancer Lett"},{"issue":"11","key":"17_CR62","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/bjc.1998.714","volume":"78","author":"T Jahkola","year":"1998","unstructured":"Jahkola T et al. (1998) Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer 78(11):1507","journal-title":"Br J Cancer"},{"issue":"2","key":"17_CR63","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V","volume":"193","author":"N Dandachi","year":"2001","unstructured":"Dandachi N et al. (2001) Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J Pathol 193(2):181\u2013189","journal-title":"J Pathol"},{"issue":"11","key":"17_CR64","first-page":"3289","volume":"62","author":"M Adams","year":"2002","unstructured":"Adams M et al. (2002) Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Res 62(11):3289\u20133297","journal-title":"Cancer Res"},{"issue":"9","key":"17_CR65","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/sj.onc.1208342","volume":"24","author":"A Scherberich","year":"2005","unstructured":"Scherberich A et al. (2005) Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro. Oncogene 24(9):1525\u20131532","journal-title":"Oncogene"},{"issue":"3","key":"17_CR66","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.gynor.2012.06.002","volume":"2","author":"T Kawakita","year":"2012","unstructured":"Kawakita T et al. (2012) Amylase-producing ovarian carcinoma: a case report and a retrospective study. Gynecol Oncol Case Rep 2(3):112\u2013114","journal-title":"Gynecol Oncol Case Rep"},{"issue":"11","key":"17_CR67","first-page":"3288","volume":"48","author":"N Tomita","year":"1988","unstructured":"Tomita N et al. (1988) Expression of \u03b1-amylase in human lung cancers. Cancer Res 48(11):3288\u20133291","journal-title":"Cancer Res"},{"issue":"5","key":"17_CR68","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1183\/09031936.94.07050941","volume":"7","author":"P Lenler-Petersen","year":"1994","unstructured":"Lenler-Petersen P et al. (1994) Alpha-amylase in resectable lung cancer. Eur Respir J 7(5):941\u2013945","journal-title":"Eur Respir J"},{"issue":"6","key":"17_CR69","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1158\/1541-7786.MCR-07-2195","volume":"6","author":"MI Hassan","year":"2008","unstructured":"Hassan MI et al. (2008) Zinc \u03b12-glycoprotein: a multidisciplinary protein. Mol Cancer Res 6(6):892\u2013906","journal-title":"Mol Cancer Res"},{"issue":"7","key":"17_CR70","first-page":"2919","volume":"30","author":"V Dubois","year":"2010","unstructured":"Dubois V et al. (2010) Zinc-\u03b12-glycoprotein: a new biomarker of breast cancer?. Anticancer Res 30(7):2919\u20132925","journal-title":"Anticancer Res"},{"issue":"9","key":"17_CR71","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/0959-8049(93)90068-Q","volume":"29","author":"I D\u00edez-Itza","year":"1993","unstructured":"D\u00edez-Itza I et al. (1993) Zn-\u03b12-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters. Eur J Cancer 29(9):1256\u20131260","journal-title":"Eur J Cancer"},{"issue":"1-2","key":"17_CR72","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0014-5793(91)81271-9","volume":"290","author":"JP Freije","year":"1991","unstructured":"Freije JP et al. (1991) Human Zn-\u03b12-glycoprotein cDNA cloning and expression analysis in benign and malignant breast tissues. FEBS Lett 290(1-2):247\u2013249","journal-title":"FEBS Lett"},{"issue":"1","key":"17_CR73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jss.2007.05.020","volume":"151","author":"A Millan","year":"2009","unstructured":"Millan A, Huerta S (2009) Apoptosis-inducing factor and colon cancer. J Surg Res 151(1):163\u2013170","journal-title":"J Surg Res"},{"issue":"52","key":"17_CR74","doi-asserted-by":"publisher","first-page":"43862","DOI":"10.1074\/jbc.M112.407650","volume":"287","author":"EM Lewis","year":"2012","unstructured":"Lewis EM et al. (2012) The enzymatic activity of apoptosis-inducing factor supports energy metabolism benefiting the growth and invasiveness of advanced prostate cancer cells. J Biol Chem 287(52):43862\u201343875","journal-title":"J Biol Chem"},{"issue":"7","key":"17_CR75","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.prp.2006.03.004","volume":"202","author":"JW Lee","year":"2006","unstructured":"Lee JW et al. (2006) Immunohistochemical analysis of apoptosis-inducing factor (AIF) expression in gastric carcinomas. Pathol Res Pract 202(7):497\u2013501","journal-title":"Pathol Res Pract"},{"issue":"1","key":"17_CR76","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0925-4439(03)00059-0","volume":"1638","author":"M Aaboe","year":"2003","unstructured":"Aaboe M et al. (2003) Vitronectin in human breast carcinomas. Biochim Biophys Acta Mol Basis Dis 1638(1):72\u201382","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"17_CR77","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/cncr.22300","volume":"107","author":"P Seve","year":"2006","unstructured":"Seve P et al. (2006) Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer 107(11):2698\u20132705","journal-title":"Cancer"},{"key":"17_CR78","unstructured":"Gopal SH, Das SK (2016) Role of lactoferrin in the carcinogenesis of triple-negative breast cancer. J Cancer Clin Trials 1(3):e105"},{"issue":"2","key":"17_CR79","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ijc.20728","volume":"114","author":"M Bena\u00efssa","year":"2005","unstructured":"Bena\u00efssa M et al. (2005) Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. Int J Cancer 114(2):299\u2013306","journal-title":"Int J Cancer"},{"issue":"1-2","key":"17_CR80","first-page":"163","volume":"17","author":"S Penco","year":"1999","unstructured":"Penco S et al. (1999) Lactoferrin expression in human breast cancer. Cancer Biochem Biophys 17(1-2):163\u2013178","journal-title":"Cancer Biochem Biophys"},{"issue":"3","key":"17_CR81","doi-asserted-by":"publisher","first-page":"181","DOI":"10.31768\/2312-8852.2016.38(3):181-186","volume":"38","author":"L Naleskina","year":"2016","unstructured":"Naleskina L et al. (2016) Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease. Exp Oncol 38(3):181\u2013186","journal-title":"Exp Oncol"},{"issue":"4","key":"17_CR82","doi-asserted-by":"publisher","first-page":"e60359","DOI":"10.1371\/journal.pone.0060359","volume":"8","author":"A Lehner","year":"2013","unstructured":"Lehner A et al. (2013) Downregulation of serine protease HTRA1 is associated with poor survival in breast cancer. PLoS One 8(4):e60359","journal-title":"PLoS One"},{"issue":"3","key":"17_CR83","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10549-011-1435-0","volume":"131","author":"R Tufail","year":"2012","unstructured":"Tufail R et al. (2012) Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas. Breast Cancer Res Treat 131(3):743\u2013750","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"17_CR84","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/cdd.2008.108","volume":"15","author":"M Yuan","year":"2008","unstructured":"Yuan M et al. (2008) Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 15(11):1752","journal-title":"Cell Death Differ"},{"issue":"1","key":"17_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-119","volume":"14","author":"S Lehn","year":"2014","unstructured":"Lehn S et al. (2014) Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response. BMC Cancer 14(1):119","journal-title":"BMC Cancer"},{"key":"17_CR86","unstructured":"https:\/\/www.proteinatlas.org\/ENSG00000172375-C2CD2L\/pathology"},{"issue":"20","key":"17_CR87","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1158\/0008-5472.CAN-14-3475","volume":"75","author":"S L\u00e9gar\u00e9","year":"2015","unstructured":"L\u00e9gar\u00e9 S et al. (2015) The estrogen receptor cofactor SPEN functions as a tumor suppressor and candidate biomarker of drug responsiveness in hormone-dependent breast cancers. Cancer Res 75(20):4351\u20134363","journal-title":"Cancer Res"},{"key":"17_CR88","volume-title":"Pat1 proteins: a life in translation, translation repression and mRNA decay","author":"A Marnef","year":"2010","unstructured":"Marnef, A, Standart, N, 2010. Pat1 proteins: a life in translation, translation repression and mRNA decay. Portland Press Limited"},{"issue":"2","key":"17_CR89","first-page":"525","volume":"12","author":"T Oberley","year":"1997","unstructured":"Oberley T, Oberley L (1997) Antioxidant enzyme levels in cancer. Histol. Histopathol 12(2):525\u2013535","journal-title":"Histol. Histopathol"},{"issue":"5","key":"17_CR90","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.kjms.2010.11.003","volume":"27","author":"S-M Tsai","year":"2011","unstructured":"Tsai S-M et al. (2011) Expression of manganese superoxide dismutase in patients with breast cancer. Kaohsiung J Med Sci 27(5):167\u2013172","journal-title":"Kaohsiung J Med Sci"},{"issue":"11","key":"17_CR91","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.freeradbiomed.2008.09.005","volume":"45","author":"MJ Hitchler","year":"2008","unstructured":"Hitchler MJ, Oberley LW, Domann FE (2008) Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells. Free Radic Biol Med 45(11):1573\u20131580","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"17_CR92","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000123849","volume":"75","author":"N Srour","year":"2008","unstructured":"Srour N, Reymond MA, Steinert R (2008) Lost in translation? A systematic database of gene expression in breast cancer. Pathobiology 75(2):112\u2013118","journal-title":"Pathobiology"},{"issue":"11","key":"17_CR93","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1182\/blood-2014-04-569939","volume":"125","author":"EP DeRoo","year":"2015","unstructured":"DeRoo EP et al. (2015) The role of galectin-3 and galectin-3\u2013binding protein in venous thrombosis. Blood 125(11):1813\u20131821","journal-title":"Blood"},{"issue":"1","key":"17_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0757-6","volume":"18","author":"M Ilmer","year":"2016","unstructured":"Ilmer M et al. (2016) Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells. Breast Cancer Res 18(1):97","journal-title":"Breast Cancer Res"},{"issue":"3-4","key":"17_CR95","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10555-012-9365-9","volume":"31","author":"J Escara-Wilke","year":"2012","unstructured":"Escara-Wilke J, Yeung K, Keller ET (2012) Raf kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev 31(3-4):615\u2013620","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"17_CR96","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bcp.2004.04.024","volume":"68","author":"ET Keller","year":"2004","unstructured":"Keller ET, Fu Z, Brennan M (2004) The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 68(6):1049\u20131053","journal-title":"Biochem Pharmacol"},{"issue":"20","key":"17_CR97","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1158\/1078-0432.CCR-05-0283","volume":"11","author":"S Hagan","year":"2005","unstructured":"Hagan S et al. (2005) Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11(20):7392\u20137397","journal-title":"Clin Cancer Res"},{"issue":"3","key":"17_CR98","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/pros.20319","volume":"66","author":"Z Fu","year":"2006","unstructured":"Fu Z et al. (2006) Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66(3):248\u2013256","journal-title":"Prostate"},{"issue":"1","key":"17_CR99","doi-asserted-by":"publisher","first-page":"145","DOI":"10.18632\/oncotarget.10426","volume":"8","author":"LN Luce","year":"2017","unstructured":"Luce LN et al. (2017) Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations. Oncotarget 8(1):145","journal-title":"Oncotarget"},{"issue":"3","key":"17_CR100","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0002-9440(10)63881-3","volume":"162","author":"A Sgambato","year":"2003","unstructured":"Sgambato A et al. (2003) Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol 162(3):849\u2013860","journal-title":"Am J Pathol"},{"issue":"8","key":"17_CR101","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1053\/hupa.2001.26468","volume":"32","author":"MD Henry","year":"2001","unstructured":"Henry MD, Cohen MB, Campbell KP (2001) Reduced expression of dystroglycan in breast and prostate cancer. Hum Pathol 32(8):791\u2013795","journal-title":"Hum Pathol"},{"issue":"8","key":"17_CR102","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10434-001-0667-3","volume":"8","author":"F Vizoso","year":"2001","unstructured":"Vizoso F et al. (2001) Lysozyme expression by breast carcinomas, correlation with clinicopathologic parameters, and prognostic significance. Ann Surg Oncol 8(8):667\u2013674","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"17_CR103","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB (2015) S100 proteins in cancer. Nat Rev Cancer 15(2):96\u2013109","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"17_CR104","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1189\/jlb.0607397","volume":"83","author":"S Ghavami","year":"2008","unstructured":"Ghavami S et al. (2008) S100A8\/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 83(6):1484\u20131492","journal-title":"J Leukoc Biol"},{"key":"17_CR105","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.biopha.2016.12.021","volume":"86","author":"A Eatemadi","year":"2017","unstructured":"Eatemadi A et al. (2017) Role of protease and protease inhibitors in cancer pathogenesis and treatment. Biomed Pharm 86:221\u2013231","journal-title":"Biomed Pharm"},{"issue":"13-14","key":"17_CR106","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/elps.202300040","volume":"44","author":"R Aslebagh","year":"2023","unstructured":"Aslebagh R et al. (2023) Proteomics analysis of human breast milk by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) coupled with mass spectrometry to assess breast cancer risk. Electrophoresis 44(13-14):1097\u20131113","journal-title":"Electrophoresis"},{"key":"17_CR107","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/proteomes10040036","volume":"10","author":"R Aslebagh","year":"2022","unstructured":"Aslebagh R et al. (2022) Mass spectrometry-based proteomics of human milk to identify differentially expressed proteins in women with breast cancer versus controls. Proteomes 10:4","journal-title":"Proteomes"},{"issue":"1-3","key":"17_CR108","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/14789450.2024.2320158","volume":"21","author":"D Whitham","year":"2024","unstructured":"Whitham D et al. (2024) Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomics. Expert Rev Proteomics 21(1-3):81\u201398","journal-title":"Expert Rev Proteomics"},{"key":"17_CR109","doi-asserted-by":"crossref","unstructured":"Darie-Ion L et al (2022) Applications of MALDI-MS\/MS-based proteomics in biomedical research. Molecules 27(19):6196","DOI":"10.3390\/molecules27196196"},{"key":"17_CR110","doi-asserted-by":"publisher","first-page":"1607258","DOI":"10.3389\/fcimb.2025.1607258","volume":"15","author":"Q Xiong","year":"2025","unstructured":"Xiong Q, Guan H (2025) Application of matrix-assisted laser desorption\/ionization time-of flight mass spectrometry in clinical testing and diagnosis. Front Cell Infect Microbiol 15:1607258","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"17_CR111","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1021\/acsmeasuresciau.2c00019","volume":"2","author":"D Li","year":"2022","unstructured":"Li D et al. (2022) MALDI-TOF Mass Spectrometry in Clinical Analysis and Research. ACS Meas Sci Au 2(5):385\u2013404","journal-title":"ACS Meas Sci Au"},{"key":"17_CR112","doi-asserted-by":"crossref","unstructured":"Jiang R, Rempel DL, Gross ML (2023) MALDI peptide mapping for fast analysis in protein footprinting. Int J Mass Spectrom 490:117080","DOI":"10.1016\/j.ijms.2023.117080"},{"issue":"1","key":"17_CR113","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13000-017-0683-7","volume":"13","author":"E Bonaparte","year":"2018","unstructured":"Bonaparte E et al. (2018) Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry. Diagn Pathol 13(1):4","journal-title":"Diagn Pathol"},{"issue":"1","key":"17_CR114","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1373\/clinchem.2015.239491","volume":"62","author":"MW Duncan","year":"2016","unstructured":"Duncan MW et al. (2016) Applications of MALDI mass spectrometry in clinical chemistry. Clin Chem 62(1):134\u2013143","journal-title":"Clin Chem"},{"issue":"1","key":"17_CR115","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5099\/aj120100085","volume":"4","author":"C Shao","year":"2012","unstructured":"Shao C et al. (2012) The use of principal component analysis in MALDI-TOF MS: a powerful tool for establishing a mini-optimized proteomic profile. Am J Biomed Sci 4(1):85\u2013101","journal-title":"Am J Biomed Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Advancements of Mass Spectrometry in Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-29437-1_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:53:07Z","timestamp":1792601587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/chapter\/10.1007\/978-3-032-29437-1_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032294364","9783032294371"],"references-count":115,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-29437-1_17","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"23 January 2027","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}